• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症基因组研究中偶然发现的披露:研究者对义务和障碍的看法

Disclosure of incidental findings in cancer genomic research: investigators' perceptions on obligations and barriers.

作者信息

Kleiderman E, Avard D, Besso A, Ali-Khan S, Sauvageau G, Hébert J

机构信息

Centre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.

Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.

出版信息

Clin Genet. 2015 Oct;88(4):320-6. doi: 10.1111/cge.12540. Epub 2014 Dec 9.

DOI:10.1111/cge.12540
PMID:25492269
Abstract

Although there has been significant research surrounding incidental findings (IFs), the guidelines and information provided to investigators remain unspecific, unclear, and often generalize the course of action to everyone in the field. We explored the perceptions and experiences of investigators regarding the return of IFs in genetic research. Researchers and clinician-researchers were invited to participate in semi-structured telephone interviews in Quebec and Ontario. Twenty professionals participated, and thematic analysis was used to analyze the transcriptions. Four contextual elements emerged: (i) degree of significance of results, (ii) respect for persons, (iii) infrastructure implications, and (iv) professional responsibilities. Our findings demonstrate that all investigators raised similar contextual elements surrounding the return of IFs. However, some nuances in participants' experiences of the understanding of professional responsibilities also emerged. Because of the existing nuances, a one-size-fits-all approach is inappropriate, suggesting that context ought to be considered in decisions about IFs.

摘要

尽管围绕偶发发现(IFs)已有大量研究,但提供给研究人员的指南和信息仍不具体、不明确,且常常将行动过程一概而论地应用于该领域的每一个人。我们探讨了研究人员对基因研究中偶发发现反馈的看法和经历。邀请了魁北克和安大略省的研究人员和临床研究人员参与半结构化电话访谈。20名专业人员参与了访谈,并采用主题分析法对访谈记录进行分析。出现了四个背景因素:(i)结果的重要程度,(ii)对人的尊重,(iii)基础设施影响,以及(iv)职业责任。我们的研究结果表明,所有研究人员都提出了围绕偶发发现反馈的类似背景因素。然而,参与者在对职业责任理解的经历中也出现了一些细微差别。由于存在这些细微差别,一刀切的方法并不合适,这表明在关于偶发发现的决策中应考虑具体情况。

相似文献

1
Disclosure of incidental findings in cancer genomic research: investigators' perceptions on obligations and barriers.癌症基因组研究中偶然发现的披露:研究者对义务和障碍的看法
Clin Genet. 2015 Oct;88(4):320-6. doi: 10.1111/cge.12540. Epub 2014 Dec 9.
2
To disclose, or not to disclose? Perspectives of clinical genomics professionals toward returning incidental findings from genomic research.是否披露?临床基因组学专业人员对从基因组研究中返还偶然发现的观点。
BMC Med Ethics. 2021 Jul 27;22(1):101. doi: 10.1186/s12910-021-00670-y.
3
'Ethical responsibility' or 'a whole can of worms': differences in opinion on incidental finding review and disclosure in neuroimaging research from focus group discussions with participants, parents, IRB members, investigators, physicians and community members.“道德责任”还是“一团麻烦事”:通过与参与者、家长、机构审查委员会成员、研究人员、医生及社区成员进行焦点小组讨论,了解在神经影像研究中对偶然发现的审查与披露方面的意见分歧
J Med Ethics. 2015 Oct;41(10):841-7. doi: 10.1136/medethics-2014-102552. Epub 2015 Jun 10.
4
Association of Researcher Characteristics with Views on Return of Incidental Findings from Genomic Research.研究者特征与对基因组研究中偶然发现结果反馈看法的关联
J Genet Couns. 2015 Oct;24(5):833-41. doi: 10.1007/s10897-014-9817-1. Epub 2015 Jan 17.
5
Perspectives and experiences of researchers regarding feedback of incidental genomic research findings: A qualitative study.研究者对偶然发现的基因组研究结果反馈的看法和经验:一项定性研究。
PLoS One. 2022 Aug 29;17(8):e0273657. doi: 10.1371/journal.pone.0273657. eCollection 2022.
6
Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting.遗传学专家对临床环境中基因组偶然发现的披露的看法。
Patient Educ Couns. 2013 Jan;90(1):133-8. doi: 10.1016/j.pec.2012.09.010. Epub 2012 Oct 12.
7
To disclose, or not to disclose? Context matters.披露,还是不披露?背景很重要。
Eur J Hum Genet. 2015 Mar;23(3):279-84. doi: 10.1038/ejhg.2014.108. Epub 2014 Jun 11.
8
Processes and factors involved in decisions regarding return of incidental genomic findings in research.研究中与返回偶然发现的基因组结果相关的决策过程和因素。
Genet Med. 2014 Apr;16(4):311-7. doi: 10.1038/gim.2013.140. Epub 2013 Sep 26.
9
Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.近7000名医疗专业人员、基因组研究人员和公众对测序研究中偶然发现结果反馈的态度。
Eur J Hum Genet. 2016 Jan;24(1):21-9. doi: 10.1038/ejhg.2015.58. Epub 2015 Apr 29.
10
Incidental Findings in Low-Resource Settings.低资源环境下的偶然发现。
Hastings Cent Rep. 2018 May;48(3):20-28. doi: 10.1002/hast.851.

引用本文的文献

1
Research biobank participants attitudes towards genetic exceptionalism and health record confidentiality.生物样本库研究参与者对基因例外论和健康记录保密性的态度。
J Community Genet. 2024 Jun;15(3):267-280. doi: 10.1007/s12687-024-00704-z. Epub 2024 Mar 5.
2
Return of individual research results from genomic research: A systematic review of stakeholder perspectives.基因组研究中个体研究结果的返还:利益相关者观点的系统评价。
PLoS One. 2021 Nov 8;16(11):e0258646. doi: 10.1371/journal.pone.0258646. eCollection 2021.
3
Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings.
是否、何时、如何以及多少?一般公众和癌症患者对基因组二级发现披露的看法。
BMC Med Genomics. 2021 Jun 26;14(1):167. doi: 10.1186/s12920-021-01016-8.
4
Primary care provider perspectives on using genomic sequencing in the care of healthy children.初级保健提供者对在健康儿童护理中使用基因组测序的看法。
Eur J Hum Genet. 2020 May;28(5):551-557. doi: 10.1038/s41431-019-0547-6. Epub 2019 Dec 5.
5
Implementation of genomics in medical practice to deliver precision medicine for an Asian population.在医学实践中实施基因组学,为亚洲人群提供精准医疗。
NPJ Genom Med. 2019 Jun 7;4:12. doi: 10.1038/s41525-019-0085-8. eCollection 2019.
6
Psychiatric genetics researchers' views on offering return of results to individual participants.精神科遗传学研究人员对向个体参与者提供研究结果回报的看法。
Am J Med Genet B Neuropsychiatr Genet. 2019 Dec;180(8):589-600. doi: 10.1002/ajmg.b.32682. Epub 2018 Oct 25.
7
Controversies among Cancer Registry Participants, Genomic Researchers, and Institutional Review Boards about Returning Participants' Genomic Results.癌症登记参与者、基因组研究人员和机构审查委员会之间关于向参与者反馈基因组结果的争议。
Public Health Genomics. 2018;21(1-2):18-26. doi: 10.1159/000490235. Epub 2018 Sep 18.
8
Public's Views toward Return of Secondary Results in Genomic Sequencing: It's (Almost) All about the Choice.公众对基因组测序二次结果反馈的看法:几乎全关乎选择。
J Genet Couns. 2017 Dec;26(6):1197-1212. doi: 10.1007/s10897-017-0095-6. Epub 2017 Mar 29.
9
Discussing molecular testing in oncology care: Comparing patient and physician information preferences.探讨肿瘤护理中的分子检测:比较患者和医生的信息偏好。
Cancer. 2017 May 1;123(9):1610-1616. doi: 10.1002/cncr.30494. Epub 2017 Jan 31.